Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients

Nevin FW Zaki,1,2 Yomna M Sabri,2 Omar Farouk,3 Amany Abdelfatah,4 David Warren Spence,5 Ahmed S Bahammam,6,7 Seithikurippu R Pandi-Perumal8 1Sleep Research Unit, Department of Psychiatry, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 2Department of Psychiatry, Faculty of Medicine, Mans...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zaki NFW, Sabri YM, Farouk O, Abdelfatah A, Spence DW, Bahammam AS, Pandi-Perumal SR
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	beck depression breast cancer chronotype circadian melatonin Psychiatry RC435-571 Neurophysiology and neuropsychology QP351-495
Acceso en línea:	https://doaj.org/article/e9b93ae676d841d9b83a4a37856f5d17
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e9b93ae676d841d9b83a4a37856f5d17
record_format	dspace
spelling	oai:doaj.org-article:e9b93ae676d841d9b83a4a37856f5d172021-12-02T04:53:59ZDepressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients1179-1608https://doaj.org/article/e9b93ae676d841d9b83a4a37856f5d172020-02-01T00:00:00Zhttps://www.dovepress.com/depressive-symptoms-sleep-profiles-and-serum-melatonin-levels-in-a-sam-peer-reviewed-article-NSShttps://doaj.org/toc/1179-1608Nevin FW Zaki,1,2 Yomna M Sabri,2 Omar Farouk,3 Amany Abdelfatah,4 David Warren Spence,5 Ahmed S Bahammam,6,7 Seithikurippu R Pandi-Perumal8 1Sleep Research Unit, Department of Psychiatry, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 2Department of Psychiatry, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 3Mansoura University Oncology Center, Mansoura, Egypt; 4Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 5Independent Researcher, Toronto, ON, Canada; 6University Sleep Disorders Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 7The Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia, Riyadh, Saudi Arabia; 8Somnogen Canada Inc, Toronto, ON, CanadaCorrespondence: Nevin FW ZakiDepartment of Psychiatry, Faculty of Medicine, Mansoura University, PO Box 36551, Mansoura, EgyptTel +201283339789Email mernakero@mans.edu.egBackground: Chronobiological changes have been detected in various physiological functions of patients with breast cancer, suggesting dysregulation in the pineal gland and melatonin secretion. This study aimed to assess and measure serum melatonin levels pre- and postoperatively in patients who had been diagnosed for the first time with breast cancer.Methods: A sample of first-time breast cancer patients, consisting of 45 women aged 25– 65 years, was evaluated and psychometric assessment was completed using the Beck Depression Inventory (BDI), Insomnia Severity Index (White, Weinberg et al) and the Epworth Sleepiness Scale (Cardoso, Spence et al). The Morningness-Eveningness questionnaire (MEQ) was used to assess the chronotype. Serum melatonin levels were measured by radioimmunoassay.Results: Morning and moderately morning chronotypes were prevalent among the sample (25%, 45.8%, respectively). The finding of a mean BDI score of 13.5± 11.2 indicated that depressive symptoms were prevalent among the sample. Despite the finding that a mean of the participants apparently had no symptoms of daytime sleepiness (the mean and standard deviations of the ESS were 7.5± 4.4), scores on the ISI (a mean of 16.7±SD 7.3) indicated that insomnia symptoms were prevalent in the sample. Melatonin levels showed an inverse relationship with insomnia severity as measured by the ISI and depression severity, as assessed by the BDI. The postoperative melatonin levels were higher than the preoperative levels. Additionally, the psychometric profile differed among various pathological types of breast cancer according to their hormone receptor profile.Conclusion: Serum melatonin levels correlated significantly with self-reported sleep quality and psychometric profiles of depression in the present sample of breast cancer patients. The melatonin assay, which is relatively easy to carry out, provided a convenient, objective measure of an important biological correlate of sleep quality and depression. This assay thus represented a confirmatory alternative to the self-report instruments, which may sometimes be unreliable. Future studies should further evaluate the utility of melatonin measures in psychiatric and sleep complaints of breast cancer patients.Keywords: beck depression, breast cancer, chronotype, circadian, melatoninZaki NFWSabri YMFarouk OAbdelfatah ASpence DWBahammam ASPandi-Perumal SRDove Medical Pressarticlebeck depressionbreast cancerchronotypecircadianmelatoninPsychiatryRC435-571Neurophysiology and neuropsychologyQP351-495ENNature and Science of Sleep, Vol Volume 12, Pp 135-149 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	beck depression breast cancer chronotype circadian melatonin Psychiatry RC435-571 Neurophysiology and neuropsychology QP351-495
spellingShingle	beck depression breast cancer chronotype circadian melatonin Psychiatry RC435-571 Neurophysiology and neuropsychology QP351-495 Zaki NFW Sabri YM Farouk O Abdelfatah A Spence DW Bahammam AS Pandi-Perumal SR Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients
description	Nevin FW Zaki,1,2 Yomna M Sabri,2 Omar Farouk,3 Amany Abdelfatah,4 David Warren Spence,5 Ahmed S Bahammam,6,7 Seithikurippu R Pandi-Perumal8 1Sleep Research Unit, Department of Psychiatry, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 2Department of Psychiatry, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 3Mansoura University Oncology Center, Mansoura, Egypt; 4Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 5Independent Researcher, Toronto, ON, Canada; 6University Sleep Disorders Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 7The Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia, Riyadh, Saudi Arabia; 8Somnogen Canada Inc, Toronto, ON, CanadaCorrespondence: Nevin FW ZakiDepartment of Psychiatry, Faculty of Medicine, Mansoura University, PO Box 36551, Mansoura, EgyptTel +201283339789Email mernakero@mans.edu.egBackground: Chronobiological changes have been detected in various physiological functions of patients with breast cancer, suggesting dysregulation in the pineal gland and melatonin secretion. This study aimed to assess and measure serum melatonin levels pre- and postoperatively in patients who had been diagnosed for the first time with breast cancer.Methods: A sample of first-time breast cancer patients, consisting of 45 women aged 25– 65 years, was evaluated and psychometric assessment was completed using the Beck Depression Inventory (BDI), Insomnia Severity Index (White, Weinberg et al) and the Epworth Sleepiness Scale (Cardoso, Spence et al). The Morningness-Eveningness questionnaire (MEQ) was used to assess the chronotype. Serum melatonin levels were measured by radioimmunoassay.Results: Morning and moderately morning chronotypes were prevalent among the sample (25%, 45.8%, respectively). The finding of a mean BDI score of 13.5± 11.2 indicated that depressive symptoms were prevalent among the sample. Despite the finding that a mean of the participants apparently had no symptoms of daytime sleepiness (the mean and standard deviations of the ESS were 7.5± 4.4), scores on the ISI (a mean of 16.7±SD 7.3) indicated that insomnia symptoms were prevalent in the sample. Melatonin levels showed an inverse relationship with insomnia severity as measured by the ISI and depression severity, as assessed by the BDI. The postoperative melatonin levels were higher than the preoperative levels. Additionally, the psychometric profile differed among various pathological types of breast cancer according to their hormone receptor profile.Conclusion: Serum melatonin levels correlated significantly with self-reported sleep quality and psychometric profiles of depression in the present sample of breast cancer patients. The melatonin assay, which is relatively easy to carry out, provided a convenient, objective measure of an important biological correlate of sleep quality and depression. This assay thus represented a confirmatory alternative to the self-report instruments, which may sometimes be unreliable. Future studies should further evaluate the utility of melatonin measures in psychiatric and sleep complaints of breast cancer patients.Keywords: beck depression, breast cancer, chronotype, circadian, melatonin
format	article
author	Zaki NFW Sabri YM Farouk O Abdelfatah A Spence DW Bahammam AS Pandi-Perumal SR
author_facet	Zaki NFW Sabri YM Farouk O Abdelfatah A Spence DW Bahammam AS Pandi-Perumal SR
author_sort	Zaki NFW
title	Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients
title_short	Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients
title_full	Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients
title_fullStr	Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients
title_full_unstemmed	Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients
title_sort	depressive symptoms, sleep profiles and serum melatonin levels in a sample of breast cancer patients
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/e9b93ae676d841d9b83a4a37856f5d17
work_keys_str_mv	AT zakinfw depressivesymptomssleepprofilesandserummelatoninlevelsinasampleofbreastcancerpatients AT sabriym depressivesymptomssleepprofilesandserummelatoninlevelsinasampleofbreastcancerpatients AT farouko depressivesymptomssleepprofilesandserummelatoninlevelsinasampleofbreastcancerpatients AT abdelfataha depressivesymptomssleepprofilesandserummelatoninlevelsinasampleofbreastcancerpatients AT spencedw depressivesymptomssleepprofilesandserummelatoninlevelsinasampleofbreastcancerpatients AT bahammamas depressivesymptomssleepprofilesandserummelatoninlevelsinasampleofbreastcancerpatients AT pandiperumalsr depressivesymptomssleepprofilesandserummelatoninlevelsinasampleofbreastcancerpatients
_version_	1718401042816696320

Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients

Ejemplares similares